Username Password
S&P 500: 1,349.74 Change: +0.07%

WISDOMTREE TRUST (DES)

Overview
Price 49.44
Price Change Today -$0.20 (-0.40%)
P&P rating Rating: 0
Open Price $49.55
Previous Close $49.64
Daily Range $49.16 - $49.72
52-Week Range $37.15 - $49.97
Volume 17
chart
Other Resources for DES
zacks.com
Commentary
Zacks Blog: Concur Joins Cloud Network
May 12, 2011
NetSuite, Inc. is the leading provider of on-demand, integrated business management software for growing and midsize businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; ecommerce; Web site management; and employee productivity.
 
Brokerage Analyst Recommendations
20 Brokerage Firms Covering N
 
    
Strong Buy
4
Buy
2
Hold
13
Sell
0
Strong Sell
1
Average Broker Recommendation (ABR): 2.55
 
N Ratings:BUY  SELL  HOLD
Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

0 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 12/22/11 Bard Buys Lutonix for $225M - Analyst Blog 0
Zacks_Analysts
0.00 12/21/11 New Year Bets from MedTech - Analyst Blog 0
Zacks_Analysts
0.00 12/06/11 Boston Scientific Remains Neutral - Analyst Blog 0
Zacks_Analysts
0.00 12/01/11 BSX Grows US CRM Portfolio - Analyst Blog 0
Zacks_Analysts
0.00 11/23/11 FDA Approves BSX Promus Element - Analyst Blog 0
Zacks_Analysts
0.00 10/20/11 BSX Beats on EPS, Revs Miss - Analyst Blog 0
Zacks_Analysts
0.00 09/20/11 Boston Scientific Grows Portfolio - Analyst Blog 0
Zacks_Analysts
0.00 08/08/11 BSX Upgraded to Outperform - Analyst Blog 0
Zacks_Analysts
0.00 07/26/11 Earnings Preview: Boston Scientific - Analyst Blog 0
Zacks_Analysts
0.00 06/16/11 J&J to Discontinue Cypher Stent - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6  >>
Commentary
There are no open picks with this stock at the moment.
Picks
There are no open picks with this stock at the moment.
Sponsored Links